NCT04931537View on ClinicalTrials.gov

Screening and Application Research of Early Diabetic Nephropathy Markers Based on Lipidomics.

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

May 1, 2021

Primary Completion Date

December 31, 2023

Study Completion Date

December 31, 2028

Conditions
Diabetic Nephropathy Type 2Biomarker
Trial Locations (1)

310009

RECRUITING

the Second Affiliated Hospital Zhejiang University Schoolof Medicine, Hangzhou

All Listed Sponsors
collaborator

Second Affiliated Hospital of Wenzhou Medical University

OTHER

collaborator

Lishui Country People's Hospital

OTHER

lead

Second Affiliated Hospital, School of Medicine, Zhejiang University

OTHER